Literature DB >> 34711547

[18F]FDG-PET Evaluation of Spinal Pathology in Patients in Oncology: Pearls and Pitfalls for the Neuroradiologist.

P Y Patel1, I Dalal1, B Griffith2.   

Abstract

[18F]FDG-PET is a widely used technique for specific evaluation of disease and treatment response in oncology. However, the principles behind [18F]FDG-PET imaging allow a wide-ranging array of benign and malignant pathologies to be identified on both initial and routine surveillance imaging. This is important for clinicians and radiologists, alike, in that effective and accurate evaluation of malignancy and metastatic disease, specifically involving the spine and central nervous system, is crucial. In this article, we review the normal and posttherapy appearance of the spine on [18F]FDG-PET, the various types and patterns of metastatic disease that involve the spine and spinal cord, and, finally, important spinal pathologies that may mimic malignancy on [18F]FDG-PET.
© 2022 by American Journal of Neuroradiology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34711547      PMCID: PMC8910786          DOI: 10.3174/ajnr.A7308

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  56 in total

1.  Vertebral hemangiomas on FDG PET scan.

Authors:  Bohdan Bybel; Shanker Raja
Journal:  Clin Nucl Med       Date:  2003-06       Impact factor: 7.794

2.  Intramedullary spinal cord metastasis.

Authors:  Debora Pellegrini; Mariano Alejandro Quezel; Julio Enrique Bruetman
Journal:  Arch Neurol       Date:  2009-11

Review 3.  Spectrum of Benign Articular and Periarticular Findings at FDG PET/CT.

Authors:  Mariah L White; Geoffrey B Johnson; Benjamin Matthew Howe; Patrick J Peller; Stephen M Broski
Journal:  Radiographics       Date:  2016 May-Jun       Impact factor: 5.333

4.  Artificial Intelligence in PET/CT Is about to Make Whole-Body Tumor Burden Measurements a Clinical Reality.

Authors:  Jerry W Froelich; Ali Salavati
Journal:  Radiology       Date:  2019-12-10       Impact factor: 11.105

5.  (18)F-FDG PET/CT for Diagnosis of Osteosclerotic and Osteolytic Vertebral Metastatic Lesions: Comparison with Bone Scintigraphy.

Authors:  Kenzo Uchida; Hideaki Nakajima; Tsuyoshi Miyazaki; Tatsuro Tsuchida; Takayuki Hirai; Daisuke Sugita; Shuji Watanabe; Naoto Takeura; Ai Yoshida; Hidehiko Okazawa; Hisatoshi Baba
Journal:  Asian Spine J       Date:  2013-05-22

6.  Value of FDG PET in the assessment of patients with multiple myeloma.

Authors:  Miriam A Bredella; Lynne Steinbach; Gary Caputo; George Segall; Randall Hawkins
Journal:  AJR Am J Roentgenol       Date:  2005-04       Impact factor: 3.959

Review 7.  Expanding role of 18F-fluoro-D-deoxyglucose PET and PET/CT in spinal infections.

Authors:  Filip Gemmel; Paul C Rijk; James M P Collins; Thierry Parlevliet; Katrin D Stumpe; Christopher J Palestro
Journal:  Eur Spine J       Date:  2010-01-06       Impact factor: 3.134

8.  Partial volume correction strategies for quantitative FDG PET in oncology.

Authors:  Nikie J Hoetjes; Floris H P van Velden; Otto S Hoekstra; Corneline J Hoekstra; Nanda C Krak; Adriaan A Lammertsma; Ronald Boellaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04-27       Impact factor: 9.236

9.  Imaging of spinal metastatic disease.

Authors:  Lubdha M Shah; Karen L Salzman
Journal:  Int J Surg Oncol       Date:  2011-11-03

Review 10.  Tumor quantification in clinical positron emission tomography.

Authors:  Bing Bai; James Bading; Peter S Conti
Journal:  Theranostics       Date:  2013-10-07       Impact factor: 11.556

View more
  1 in total

Review 1.  State-of-the-Art Imaging Techniques in Metastatic Spinal Cord Compression.

Authors:  Tricia Kuah; Balamurugan A Vellayappan; Andrew Makmur; Shalini Nair; Junda Song; Jiong Hao Tan; Naresh Kumar; Swee Tian Quek; James Thomas Patrick Decourcy Hallinan
Journal:  Cancers (Basel)       Date:  2022-07-05       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.